High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
Phetsouphanh, Chansavath, Khoo, Weng Hua, Jackson, Katherine, Klemm, Vera, Howe, Annett, Aggarwal, Anupriya, Akerman, Anouschka, Milogiannakis, Vanessa, Stella, Alberto Ospina, Rouet, Romain, Schofield, Peter, Faulks, Megan L, Law, Hannah, Danwilai, Thidarat, Starr, Mitchell, Munier, C Mee Ling, Christ, Daniel, Singh, Mandeep, Croucher, Peter I, Brilot-Turville, Fabienne, Turville, Stuart, Phan, Tri Giang, Dore, Gregory J, Darley, David, Cunningham, Philip, Matthews, Gail V, Kelleher, Anthony D, Zaunders, John J
Published in Frontiers in immunology (05.12.2022)
Published in Frontiers in immunology (05.12.2022)
Get full text
Journal Article
Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection
Catlett, Beth, Starr, Mitchell, Machalek, Dorothy A, Danwilai, Thidarat, Palmer, Michael, Kelly, Andrew, Kaldor, John, Dore, Gregory J, Darley, David, Matthews, Gail, Cunningham, Philip H.
Published in Journal of clinical virology plus (01.08.2022)
Published in Journal of clinical virology plus (01.08.2022)
Get full text
Journal Article